Drug Standards
Rivastigmine Related Compound A, Pharmaceutical Secondary Standard, Certified Reference Material, MilliporeSigma™ Supelco™
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
Amikacin Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Amikacin is an aminoglycoside antibiotic. It is a semisynthetic analog of kanamycin and is effective against most gram-negative bacteria. It is used for the treatment of skin infections.
Sisomicin Sulfate Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Sisomicin Sulfate is the sulfate salt of sisomicin, an aminoglycoside antibiotic isolated from Micromonopora inyoensis. It is highly effective against most strains of Klebsiella spp., Escherichia coli, P. aeruginosa, Enterobacter and Proteus spp. It is a potential treatment for conjunctiva.
Paclitaxel Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
Cytarabine Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
Malic acid Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Malic acid is a naturally occurring acidulant and low acid food additive, present in most fruits and vegetables. It is widely used to enhance the flavor, adjust the pH value of alkaline products and to control the growth of bacteria.
Sitagliptin Phosphate Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
An anti-diabetic (antihyperglycemic) drug of the dipeptidyl peptidase-4 (DPP-4) class. Inhibition of the enzyme DPP-4 is thought to increase Glucagon-like peptide-1 (GLP-1) which inhibits glucagon release, stimulates insulin release and lowers blood glucose.
